BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 01, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Elucigene FH20 regulatory update

The U.K.'s NICE issued draft guidance recommending against the use of the genetic tests Elucigene FH20 from Gen-Probe and LIPOchip from Progenika Biopharma S.A. (Derio, Spain) to confirm a clinical diagnosis of familial hypercholesterolemia ( FH), or for the screening of relatives...

Read the full 213 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >